Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment

Scott, David

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment

Version 2 2024-06-19, 19:08

Version 1 2023-05-26, 05:35

journal contribution

posted on 2024-06-19, 19:08 authored by David ScottDavid Scott

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment

History

Journal

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY

Volume

6

Pagination

359-363

Location

New Zealand

Publisher DOI

https://doi.org/10.2147/DMSO.S51795

ISSN

1178-7007

eISSN

1178-7007

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213944000036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

CN.1 Other journal article

Publisher

DOVE MEDICAL PRESS LTD

Publication URL

http://dx.doi.org/10.2147/dmso.s51795

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism renal impairment incretin DPP-4 inhibitor type 2 diabetes EFFICACY SAFETY

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Author URL

Publication classification

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports